Prevention and management of ovarian hyperstimulation syndrome

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 6, 2012, Pages 817-827

  Chen, Chin Der ^a   Chen, Shee Uan ^a   Yang, Yu Shih ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

complications; management; ovarian hyperstimulation syndrome; prevention

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; BUSERELIN; CABERGOLINE; CHORIONIC GONADOTROPIN; DALTEPARIN; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENOXAPARIN; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HEPARIN; HETASTARCH; LEUPRORELIN; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; OPIATE; PARACETAMOL; PROGESTERONE; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; COASTING; CRYOPRESERVATION; CYCLE CANCELLATION; DEHYDRATION; DISEASE SEVERITY; DRUG DOSE COMPARISON; EMBRYO FREEZING; FEMALE; FERTILIZATION IN VITRO; FREEZING; HEMOCONCENTRATION; HUMAN; INTENSIVE CARE; INTRACYTOPLASMIC SPERM INJECTION; INTRAVASCULAR DEHYDRATION; KIDNEY FAILURE; KIDNEY PERFUSION; LOW DRUG DOSE; LUNG FUNCTION; OOCYTE FREEZING; OOCYTE MATURATION; OUTPATIENT CARE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; PAIN; PARACENTESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PLEURA EFFUSION; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK REDUCTION; SINGLE DRUG DOSE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; VASCULARIZATION;

FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PARACENTESIS; RISK ASSESSMENT;

EID: 84867839902     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2012.04.004     Document Type: Article

References (71)

1. J.J. Madill, N.B. Mullen, and B.P. Harrison Ovarian hyperstimulation syndrome: a potentially fatal complication of early pregnancy J Emerg Med 35 2008 283 286
2. Polishuk, and J.G. Schenker Ovarian overstimulation syndrome Fertil Steril 20 1969 443 450
3. S.U. Chen, R.J. Chen, and J.Y. Shieh Human chorionic gonadotrophin up-regulates expression of myeloid cell leukemia-1 protein in human granulosa-lutein cells: implication of corpus luteum rescue and ovarian hyperstimulation syndrome J Clin Endocrinol Metab 95 2010 3982 3992
4. S.U. Chen, C.H. Chou, and C.W. Lin Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways Hum Reprod 25 2010 757 767
5. N. McClure, D.L. Healy, and P.A.W. Rogers Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome Lancet 344 1994 235 236
6. A. Delvigne, and S. Rozenberg Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS) Hum Reprod Update 9 2003 77 96
7. O. Beji, N. Brahmi, and H. Thabet Compressive pleural effusion after ovarian hyperstimulation syndrome - a case report and review Fertil Steril 89 2008 1826.e1 1826.e3
8. C.D. Chen, M.Y. Wu, and H.F. Chen Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome Hum Reprod 15 2000 66 71
9. W.S. Chan The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology Curr Opin Obstet Gynecol 21 2009 207 218
10. A. Delvigne, A. Demoulin, and J. Smitz The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features Hum Reprod 8 1993 1353 1360
11. G.I. Serour, M. Aboulghar, and R. Mansour Complications of medically assisted conception in 3500 cycles Fertil Steril 70 1998 638 642
12. K. Rova, H. Passmark, and P.G. Lindqvist Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Fertil Steril 97 2012 95 100
13. A. Raziel, M. Schachter, and S. Friedler Outcome of IVF pregnancies following severe OHSS Reprod Biomed Online 19 2009 61 65
14. B. Luke, M.B. Brown, and D.E. Morbeck Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome Fertil Steril 94 2010 1399 1404
15. B. Courbiere, V. Oborski, and D. Braunstein Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study Fertil Steril 95 2011 1629 1632
16. W. Al Omari, S. Ghazal-Aswad, and I.H. Sidky Ovarian salvage in bilaterally complicated severe ovarian hyperstimulation syndrome Fertil Steril 96 2011 e77 e79
17. Royal College of Obstetricians and Gynaecologists (RCOG) The management of ovarian hyperstimulation syndrome, Green-top guideline, number 5 2006 RCOG London 1-11
18. Practice Committee of American Society for Reproductive Medicine (ASRM) Ovarian hyperstimulation syndrome Fertil Steril 90 2008 S188 S193
19. A. Golan, R. Ron-El, and A. Herman Ovarian hyperstimulation syndrome: an update review Obstet Gynecol Surv 44 1989 430 440
20. D. Navot, P.A. Bergh, and N. Laufer Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment Fertil Steril 58 1992 249 261
21. A. Golan, and A. Weissman Symposium: update on prediction and management of OHSS. A modern classification of OHSS Reprod Biomed Online 19 2009 28 32
22. R.S. Mathur, A.V. Akande, and S.D. Keay Distinction between early and late ovarian hyperstimulation syndrome Fertil Steril 73 2000 901 907
23. J.A. Garcia-Velasco Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos Fertil Steril 97 2012 527 528
24. S.L. Broer, M. Dólleman, and B.C. Opmeer AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum Reprod Update 17 2011 46 54
25. T.H. Lee, C.H. Liu, and C.C. Huang Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum Reprod 23 2008 160 167
26. P. Ocal, S. Sahmay, and M. Cetin Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles J Assist Reprod Genet 28 2011 1197 1203
27. F. Olivennes Ovarian hyperstimulation syndrome prevention strategies: individualizing gonadotrophin dose Semin Reprod Med 28 2010 463 467
28. A. Enskog, M. Henriksson, and M. Unander Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization Fertil Steril 71 1999 808 814
29. R. Homburg, and C.M. Howles Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements Hum Reprod Update 5 1999 493 499
30. E.J. van Santbrink, and B.C. Fauser Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens J Clin Endocrinol Metab 82 1997 3597 3602
31. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome Hum Reprod 23 2008 462 477
32. H.G. Al-Inany, M.A. Youssef, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst Rev 5 2011 CD001750
33. J. Pundir, S.K. Sunkara, and T. El-Toukhy Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? Reprod Biomed Online 24 2012 6 22
34. J.Y. Huang, R.C. Chian, and S.L. Tan Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation Semin Reprod Med 28 2010 519 531
35. J.E.J. Smitz, J.G. Thompson, and R.B. Gilchrist The promise of in vitro maturation in assisted reproduction and fertility preservation Semin Reprod Med 29 2011 24 37
36. T. Tang, J. Glanville, and N. Orsi The use of metformin for women with PCOS undergoing IVF treatment Hum Reprod 21 2006 1416 1425
37. L.O. Tso, M.F. Costello, and L.E. Albuquerque Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome Cochrane Database Syst Rev 15 2009 CD006105
38. S. Palomba, A. Falbo, and L. Carrillo Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotrophin-stimulated in vitro fertilization cycles: a randomized, controlled trial Fertil Steril 96 2011 1384 1390.e4
39. R.G. Forman, R. Frydman, and D. Egan Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention Fertil Steril 53 1990 502 509
40. A. Delvigne, and S. Rozenberg A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients Hum Reprod Update 8 2002 291 296
41. A. D'Angelo, J. Brown, and N.N. Amso Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev 6 2011 CD002811
42. C.D. Chen, K.H. Chao, and J.H. Yang Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome Fertil Steril 80 2003 86 90
43. R. Abdallah, I. Kligman, and O. Davis Withholding gonadotrophins until human chorionic gonadotrophin administration Semin Reprod Med 28 2010 486 492
44. J.A. Garcia-Velasco, V. Isaza, and G. Quea Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? Fertil Steril 85 2006 547 554
45. M.A. Youssef, H.G. Al-Inany, and J.L. Evers Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome Cochrane Database Syst Rev 16 2011 CD001302
46. C.A. Venetis, E.M. Kolibianakis, and K.A. Toulis Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis Fertil Steril 95 2011 188 196
47. I. Tsoumpou, J. Muglu, and T.A. Gelbaya Symposium: update on prediction and management of OHSS. Optimal dose of HCG for final oocyte maturation in IVF cycles: absence of evidence? Reprod Biomed Online 19 2009 52 58
48. P. Humaidan Agonist trigger: what is the best approach? Agonist trigger and low dose hCG Fertil Steril 97 2012 529 530
49. E.G. Papanikolaou, W. Verpoest, and H. Fatemi A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotrophin- releasing hormone agonist is used instead of human chorionic gonadotrophin for ovulation triggering: a randomized prospective proof of concept study Fertil Steril 95 2011 1174 1177
50. P. Humaidan, H.E. Bredkjaer, and L. Bungum GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
51. J.C. Castillo, M. Dolz, and E. Bienvenido Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support Reprod Biomed Online 20 2010 175 181
52. P. Humaidan, H.E. Bredkjaer, and L.G. Westergaard 1500 IU human chorionic gonadotrophin administered at oocyte retrieval rescues the luteal phase when gonadotrophin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
53. P. Humaidan, S. Kol, and E. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524
54. M. Cerrillo, S. Rodríguez, and M. Mayoral Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction Fertil Steril 91 2009 1526 1528
55. M. Melo, C.E. Busso, and J. Bellver GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study Reprod Biomed Online 19 2009 486 492
56. M. van der Linden, K. Buckingham, and C. Farquhar Luteal phase support for assisted reproduction cycles Cochrane Database Syst Rev 5 2011 CD009154
57. A. D'Angelo, and N. Amso Embryo freezing for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev 18 2007 CD002806
58. P. Humaidan, J. Quartarolo, and E.G. Papanikolaou Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil Steril 94 2010 389 400
59. G. Griesinger, L. Schultz, and T. Bauer Ovarian hyperstimulation syndrome prevention by gonadotrophin-releasing hormone agonist triggering of final oocyte maturation in a gonadotrophin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study Fertil Steril 95 2011 2029 2033
60. S. Basu, J.A. Nagy, and S. Pal The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor Nat Med 7 2001 569 574
61. M.A. Youssef, M. van Wely, and M.A. Hassan Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis Hum Reprod Update 16 2010 459 466
62. A. Varnagy, J. Bodis, and Z. Manfai Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome Fertil Steril 93 2009 2281 2284
63. J.G. Whelan 3rd, and N.F. Vlahos The ovarian hyperstimulation syndrome Fertil Steril 73 2000 883 896
64. L.P. Smith, M.R. Hacker, and M.M. Alper Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Fertil Steril 92 2009 1953 1959
65. J.M. Csokmay, B.J. Yauger, and M.B. Henne Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "Tap early and often" versus hospitalization Fertil Steril 93 2010 167 173
66. C.D. Chen, J.H. Yang, and K.H. Chao Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome Hum Reprod 13 1998 2077 2081
67. M.T. Ozgun, C. Batukan, and G. Oner Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome Gynecol Endocrinol 24 2008 656 658
68. M. Al-Ramahi, A. Leader, and P. Claman A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome Hum Reprod 12 1997 2614 2616
69. M.I. Abuzeid, Z. Nassar, and Z. Massaad Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome Hum Reprod 18 2003 370 373
70. S.M. Nelson Prophylaxis of VTE in women - during assisted reproductive techniques Thromb Res 123 Suppl. 3 2009 S8 S15
71. P.A. Vardhana, M.A. Julius, and S.V. Pollak A unique human chorionic gonadotrophin antagonist suppresses ovarian hyperstimulation syndrome in rats Endocrinology 150 2009 3807 3814